US 9549934
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
granted A61KA61K31/4178A61K31/4184
Quick answer
US patent 9549934 (Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities) held by Almirall, S.A. expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Almirall, S.A.
- Grant date
- Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/4178, A61K31/4184, A61K31/423, A61K31/428